Su‐Hyung Park

7.4k total citations · 1 hit paper
116 papers, 4.2k citations indexed

About

Su‐Hyung Park is a scholar working on Immunology, Oncology and Hepatology. According to data from OpenAlex, Su‐Hyung Park has authored 116 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Immunology, 36 papers in Oncology and 26 papers in Hepatology. Recurrent topics in Su‐Hyung Park's work include Immune Cell Function and Interaction (56 papers), Cancer Immunotherapy and Biomarkers (29 papers) and T-cell and B-cell Immunology (28 papers). Su‐Hyung Park is often cited by papers focused on Immune Cell Function and Interaction (56 papers), Cancer Immunotherapy and Biomarkers (29 papers) and T-cell and B-cell Immunology (28 papers). Su‐Hyung Park collaborates with scholars based in South Korea, United States and Japan. Su‐Hyung Park's co-authors include Eui‐Cheol Shin, Barbara Rehermann, Pil Soo Sung, Seong Jin Choi, Hye Won Jeong, Moa Sa, Seongju Jeong, Hoyoung Lee, Min Hwan Kim and Inkyung Jung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Su‐Hyung Park

113 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

2020 530 citations Hye Won Jeong, Seong Jin Choi et al. Science Immunology profile →

Peers

Countries citing papers authored by Su‐Hyung Park

Since Specialization

Citations

This map shows the geographic impact of Su‐Hyung Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Hyung Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Hyung Park more than expected).

Fields of papers citing papers by Su‐Hyung Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Hyung Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Hyung Park. The network helps show where Su‐Hyung Park may publish in the future.

Co-authorship network of co-authors of Su‐Hyung Park

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Hyung Park. A scholar is included among the top collaborators of Su‐Hyung Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Hyung Park. Su‐Hyung Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4⁺ T Cells 2025 ·Immune Network ·(unknown), June‐Young Koh, Min‐Seok Rha, (unknown), Jae‐Hoon Ko, Hee Kyoung Choi, Ji Hoon Jeon, Hyeri Seok, Dae Won Park, Kyong Ran Peck, Jun Yong Choi, Su‐Hyung Park, Won Suk Choi, Hye Won Jeong, Eui‐Cheol Shin	0
2	Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance 2024 ·SHILAP Revista de lepidopterología ·Ji Won Han, Su‐Hyung Park	2
3	Oligonucleotide‐Linked Lipid Nanoparticles as a Versatile mRNA Nanovaccine Platform 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), (unknown), Su‐Hyung Park, Hyun Jung Chung	0
4	Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade 2024 ·Clinical Cancer Research ·Seung Hyuck Jeon, (unknown), Junsik Park, (unknown), (unknown), (unknown), (unknown), (unknown), Woo‐Chan Son, (unknown), Eui‐Cheol Shin, Jung‐Yun Lee, Dai Hoon Han, Jaeho Jung, Su‐Hyung Park	6
5	Inhalation Delivery of Interferon-λ-Loaded Pulmonary Surfactant Nanoparticles Induces Rapid Antiviral Immune Responses in the Lung 2024 ·ACS Applied Materials & Interfaces ·(unknown), (unknown), (unknown), (unknown), Junhee Han, Sung‐Dong Cho, Su‐Hyung Park, Ji‐Ho Park, Hyun Jik Kim	6
6	Omicron BA.2 breakthrough infection elicits CD8 ⁺ T cell responses recognizing the spike of later Omicron subvariants 2024 ·Science Immunology ·(unknown), Jihye Kim, (unknown), Ji Yun Noh, Jin Nam Kim, Heedo Park, Young Goo Song, Kyong Ran Peck, Su‐Hyung Park, Man‐Seong Park, Jae‐Hoon Ko, Joon Young Song, Jun Yong Choi, (unknown), Eui‐Cheol Shin	7
7	Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets 2023 ·mBio ·Do-Kyun Kim, Eun-Ha Kim, Se‐Mi Kim, (unknown), Chih‐Jen Lai, In–Ho Cha, Sung‐Dong Cho, (unknown), Xinghong Dai, Stephanie Kim, (unknown), (unknown), Ziyi Liu, Younho Choi, Su‐Hyung Park, Young Ki Choi, Jae U. Jung	23
8	CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy 2023 ·Clinical Cancer Research ·Seung Hyuck Jeon, Minyong Kang, (unknown), (unknown), (unknown), Yong Joon Lee, (unknown), (unknown), Junsik Park, Jung‐Yun Lee, Eui‐Cheol Shin, Seong Il Seo, Su‐Hyung Park	10
9	Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer 2023 ·British Journal of Cancer ·Junsik Park, Jung Chul Kim, Mi‐Ran Lee, (unknown), Yoo‐Na Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Su‐Hyung Park, Jung‐Yun Lee	6
10	A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity 2023 ·Nature Immunology ·Joon Seok, Sung‐Dong Cho, (unknown), (unknown), Su‐Young Kim, Sungmin Lee, (unknown), Seongju Jeong, (unknown), Hoyoung Lee, (unknown), Baekgyu Choi, Sang‐Jun Ha, Inkyung Jung, Ki‐Jun Yoon, Jong-Eun Park, Jong Hoon Kim, Beom Joon Kim, Eui‐Cheol Shin, Su‐Hyung Park	20
11	Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19 2023 ·The Journal of Immunology ·(unknown), June‐Young Koh, Jae Hyung Jung, Hyeongseok Jeong, Hye Won Jeong, Shinhye Cheon, Su‐Hyung Park, Kim Ys, Eui‐Cheol Shin	5
12	Roles of Virtual Memory T Cells in Diseases 2023 ·Immune Network ·Joon Seok, Sung‐Dong Cho, Seong Jun Seo, Su‐Hyung Park	10
13	CD39 ⁺ tissue-resident memory CD8 ⁺ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer 2022 ·Science Immunology ·Yong Joon Lee, Jee Ye Kim, Seung Hyuck Jeon, (unknown), Jae Hyung Jung, (unknown), (unknown), Soong June Bae, (unknown), Tae-Kyung Yoo, Woo Young Sun, Sung Gwe Ahn, Joon Jeong, Su‐Hyung Park, Woo Chan Park, Seung Il Kim, Eui‐Cheol Shin	34
14	Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma 2021 ·Clinical Cancer Research ·Hyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, Chang Gon Kim, Haerim Chung, Yoon Seok Choi, Su‐Hyung Park, June‐Won Cheong, Yoo Hong Min, Eui‐Cheol Shin, Jin Seok Kim	31
15	Longitudinal Intravital Imaging of Tumor-Infiltrating Lymphocyte Motility in Breast Cancer Models 2021 ·Journal of Breast Cancer ·Inwon Park, (unknown), Joon Seok, (unknown), Eunjoo Song, Mingyo Kim, (unknown), Howon Seo, Yoonha Hwang, Soyeon Ahn, (unknown), Dong‐Hyun Jang, Jae Hyuk Lee, Su‐Hyung Park, Pilhan Kim, You Hwan Jo	4
16	PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors 2020 ·Clinical Cancer Research ·Minsuk Kwon, (unknown), Hoyoung Lee, Hyunsoo Cho, (unknown), (unknown), Seong Jin Choi, Junsik Park, In‐Ho Seo, Bjarne Bogen, Ik‐Chan Song, Deog‐Yeon Jo, Jin Seok Kim, Su‐Hyung Park, Inhak Choi, Yoon Seok Choi, Eui‐Cheol Shin	34
17	Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling 2020 ·Cancer Immunology Research ·Jimin Son, (unknown), (unknown), Jihyun Moon, (unknown), Hoyoung Lee, (unknown), Gamin Kim, (unknown), Sérgio A. Lira, Andrew N. J. McKenzie, Hye Young Kim, Cheol Yong Choi, Yong Taik Lim, Sung Yong Park, (unknown), Su‐Hyung Park, Eui‐Cheol Shin, Insuk Lee, Sang‐Jun Ha	38
18	The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors 2019 ·Clinical Cancer Research ·Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su‐Hyung Park, Keunchil Park, Myung‐Ju Ahn, Eui‐Cheol Shin	132
19	Increased frequency of CD4+CD57+ senescent T cells in patients with newly diagnosed acute heart failure: exploring new pathogenic mechanisms with clinical relevance 2019 ·Scientific Reports ·Jong‐Chan Youn, Min Kyung Jung, Hee Tae Yu, Ji‐Soo Kwon, Jeong-Eun Kwak, Su‐Hyung Park, In‐Cheol Kim, Myung Soo Park, (unknown), (unknown), Seongwoo Han, Kyu-Hyung Ryu, Seok‐Min Kang, Eui‐Cheol Shin	35
20	YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma 2018 ·Cancer Immunology Research ·Min Hwan Kim, Chang Gon Kim, Sang Kyum Kim, Sang Joon Shin, Eun‐Ah Choe, Su‐Hyung Park, Eui‐Cheol Shin, Joon Kim	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact